|
1
|
Stillwell W and Wassall SR:
Docosahexaenoic acid: Membrane properties of a unique fatty acid.
Chem Phys Lipids. 126:1–27. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirayama T: Epidemiology of breast cancer
with special reference to the role of diet. Prev Med. 7:173–195.
1978. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wynder EL, Rose DP and Cohen LA: Diet and
breast cancer in causation and therapy. Cancer. 58:(Suppl 8).
S1804–S1813. 1986. View Article : Google Scholar
|
|
4
|
Rose DP, Connolly JM and Coleman M: Effect
of omega-3 fatty acids on the progression of metastases after the
surgical excision of human breast cancer cell solid tumors growing
in nude mice. Clin Cancer Res. 2:1751–1756. 1996.PubMed/NCBI
|
|
5
|
Wu M, Harvey KA, Ruzmetov N, Welch ZR,
Sech L, Jackson K, Stillwell W, Zaloga GP and Siddiqui RA: Omega-3
polyunsaturated fatty acids attenuate breast cancer growth through
activation of a neutral sphingomyelinase-mediated pathway. Int J
Cancer. 117:340–348. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bartsch H, Nair J and Owen RW: Dietary
polyunsaturated fatty acids and cancers of the breast and
colorectum: Emerging evidence for their role as risk modifiers.
Carcinogenesis. 20:2209–2218. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Larsson SC, Kumlin M, Ingelman-Sundberg M
and Wolk A: Dietary long-chain n-3 fatty acids for the prevention
of cancer: A review of potential mechanisms. Am J Clin Nutr.
79:935–945. 2004.PubMed/NCBI
|
|
8
|
Chambers AF and Matrisian LM: Changing
views of the role of matrix metalloproteinases in metastasis. J
Natl Cancer Inst. 89:1260–1270. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nakajima M, Welch DR, Belloni PN and
Nicolson GL: Degradation of basement membrane type IV collagen and
lung subendothelial matrix by rat mammary adenocarcinoma cell
clones of differing metastatic potentials. Cancer Res.
47:4869–4876. 1987.PubMed/NCBI
|
|
10
|
Woessner JF Jr: Matrix metalloproteinases
and their inhibitors in connective tissue remodeling. FASEB J.
5:2145–2154. 1991.PubMed/NCBI
|
|
11
|
Velinov N, Poptodorov G, Gabrovski N and
Gabrovski S: The role of matrixmetalloproteinases in the tumor
growth and metastasis. Khirurgiia (Sofiia). 44–49. 2010.(In
Bulgarian). PubMed/NCBI
|
|
12
|
Brinckerhoff CE and Matrisian LM: Matrix
metalloproteinases: A tail of a frog that became a prince. Nat Rev
Mol Cell Biol. 3:207–214. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Gum R, Wang H, Lengyel E, Juarez J and
Boyd D: Regulation of 92 kDa type IV collagenase expression by the
jun aminoterminal kinase- and the extracellular signal-regulated
kinase-dependent signaling cascades. Oncogene. 14:1481–1493. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Newton AC: Regulation of protein kinase C.
Curr Opin Cell Biol. 9:161–167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zeigler ME, Chi Y, Schmidt T and Varani J:
Role of ERK and JNK pathways in regulating cell motility and matrix
metalloproteinase 9 production in growth factor-stimulated human
epidermal keratinocytes. J Cell Physiol. 180:271–284. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hozumi A, Nishimura Y, Nishiuma T, Kotani
Y and Yokoyama M: Induction of MMP-9 in normal human bronchial
epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am J
Physiol Lung Cell Mol Physiol. 281:L1444–L1452. 2001.PubMed/NCBI
|
|
17
|
Weng CJ, Chau CF, Hsieh YS, Yang SF and
Yen GC: Lucidenic acid inhibits PMA-induced invasion of human
hepatoma cells through inactivating MAPK/ERK signal transduction
pathway and reducing binding activities of NF-kappaB and AP-1.
Carcinogenesis. 29:147–156. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin CW, Hou WC, Shen SC, Juan SH, Ko CH,
Wang LM and Chen YC: Quercetin inhibition of tumor invasion via
suppressing PKC delta/ERK/AP-1-dependent matrix metalloproteinase-9
activation in breast carcinoma cells. Carcinogenesis. 29:1807–1815.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee SO, Jeong YJ, Kim M, Kim CH and Lee
IS: Suppression of PMA-induced tumor cell invasion by capillarisin
via the inhibition of NF-kappaB-dependent MMP-9 expression. Biochem
Biophys Res Commun. 366:1019–1024. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Oh JH, Chung AS, Steinbrenner H, Sies H
and Brenneisen P: Thioredoxin secreted upon ultraviolet A
irradiation modulates activities of matrix metalloproteinase-2 and
tissue inhibitor of metalloproteinase-2 in human dermal
fibroblasts. Arch Biochem Biophys. 423:218–226. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hong S, Park KK, Magae J, Ando K, Lee TS,
Kwon TK, Kwak JY, Kim CH and Chang YC: Ascochlorin inhibits matrix
metalloproteinase-9 expression by suppressing activator
protein-1-mediated gene expression through the ERK1/2 signaling
pathway: Inhibitory effects of ascochlorin on the invasion of renal
carcinoma cells. J Biol Chem. 280:25202–25209. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Woo MS, Jung SH, Kim SY, Hyun JW, Ko KH,
Kim WK and Kim HS: Curcumin suppresses phorbol ester-induced matrix
metalloproteinase-9 expression by inhibiting the PKC to MAPK
signaling pathways in human astroglioma cells. Biochem Biophys Res
Commun. 335:1017–1025. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Eberhardt W, Huwiler A, Beck KF, Walpen S
and Pfeilschifter J: Amplification of IL-1 beta-induced matrix
metalloproteinase-9 expression by superoxide in rat glomerular
mesangial cells is mediated by increased activities of NF-kappa B
and activating protein-1 and involves activation of the
mitogen-activated protein kinase pathways. J Immunol.
165:5788–5797. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Karin M: The regulation of AP-1 activity
by mitogen-activated protein kinases. J Biol Chem. 270:16483–16486.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Madrid LV, Mayo MW, Reuther JY and Baldwin
AS Jr: Akt stimulates the transactivation potential of the RelA/p65
Subunit of NF-kappa B through utilization of the Ikappa B kinase
and activation of the mitogen-activated protein kinase p38. J Biol
Chem. 276:18934–18940. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Delerive P, Fruchart JC and Staels B:
Peroxisome proliferator-activated receptors in inflammation
control. J Endocrinol. 169:453–459. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Daynes RA and Jones DC: Emerging roles of
PPARs in inflammation and immunity. Nat Rev Immunol. 2:748–759.
2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lee JH, Woo JH, Woo SU, Kim KS, Park SM,
Joe EH and Jou I: The 15-deoxy-delta 12,14-prostaglandin J2
suppresses monocyte chemoattractant protein-1 expression in
IFN-gamma-stimulated astrocytes through induction of MAPK
phosphatase-1. J Immunol. 181:8642–8649. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Li CC, Yang HT, Hou YC, Chiu YS and Chiu
WC: Dietary fish oil reduces systemic inflammation and ameliorates
sepsis-induced liver injury by up-regulating the peroxisome
proliferator-activated receptor gamma-mediated pathway in septic
mice. J Nutr Biochem. 25:19–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee YR, Noh EM, Oh HJ, Hur H, Kim JM, Han
JH, Hwang JK, Park BH, Park JW, Youn HJ, et al:
Dihydroavenanthramide D inhibits human breast cancer cell invasion
through suppression of MMP-9 expression. Biochem Biophys Res
Commun. 405:552–557. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim JM, Noh EM, Kwon KB, Kim JS, You YO,
Hwang JK, Hwang BM, Kim BS, Lee SH, Lee SJ, et al: Curcumin
suppresses the TPA-induced invasion through inhibition of
PKCalpha-dependent MMP-expression in MCF-7 human breast cancer
cells. Phytomedicine. 19:1085–1092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim JM, Noh EM, Kwon KB, Kim JS, You YO,
Hwang JK, Hwang BM, Kim MS, Lee SJ, Jung SH, et al: Suppression of
TPA-induced tumor cell invasion by sulfuretin via inhibition of
NF-κB-dependent MMP-9 expression. Oncol Rep. 29:1231–1237.
2013.PubMed/NCBI
|
|
33
|
Bradford MM: A rapid and sensitive method
for the quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem. 72:248–254.
1976. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Altenburg JD, Bieberich AA, Terry C,
Harvey KA, Vanhorn JF, Xu Z, Jo Davisson V and Siddiqui RA: A
synergistic antiproliferation effect of curcumin and
docosahexaenoic acid in SK-BR-3 breast cancer cells: Unique
signaling not explained by the effects of either compound alone.
BMC Cancer. 11:1492011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kim J, Lim SY, Shin A, Sung MK, Ro J, Kang
HS, Lee KS, Kim SW and Lee ES: Fatty fish and fish omega-3 fatty
acid intakes decrease the breast cancer risk: A case-control study.
BMC Cancer. 9:2162009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sun H, Berquin IM, Owens RT, O'Flaherty JT
and Edwards IJ: Peroxisome proliferator-activated receptor
gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids
promotes apoptosis of human breast cancer cells. Cancer Res.
68:2912–2919. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Scorilas A, Karameris A, Arnogiannaki N,
Ardavanis A, Bassilopoulos P, Trangas T and Talieri M:
Overexpression of matrix-metalloproteinase-9 in human breast
cancer: A potential favourable indicator in node-negative patients.
Br J Cancer. 84:1488–1496. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Cho HJ, Kang JH, Kwak JY, Lee TS, Lee IS,
Park NG, Nakajima H, Magae J and Chang YC: Ascofuranone suppresses
PMA-mediated matrix metalloproteinase-9 gene activation through the
Ras/Raf/MEK/ERK- and Ap1-dependent mechanisms. Carcinogenesis.
28:1104–1110. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Kajanne R, Miettinen P, Mehlem A, Leivonen
SK, Birrer M, Foschi M, Kahari VM and Leppa S: EGF-R regulates MMP
function in fibroblasts through MAPK and AP-1 pathways. J Cell
Physiol. 212:489–497. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Srivastava AK, Qin X, Wedhas N, Arnush M,
Linkhart TA, Chadwick RB and Kumar A: Tumor necrosis factor-alpha
augments matrix metalloproteinase-9 production in skeletal muscle
cells through the activation of transforming growth
factor-beta-activated kinase 1 (TAK1)-dependent signaling pathway.
J Biol Chem. 282:35113–35124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Frigo DE, Tang Y, Beckman BS, Scandurro
AB, Alam J, Burow ME and McLachlan JA: Mechanism of AP-1-mediated
gene expression by select organochlorines through the p38 MAPK
pathway. Carcinogenesis. 25:249–261. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shaulian E and Karin M: AP-1 in cell
proliferation and survival. Oncogene. 20:2390–2400. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yokoo T and Kitamura M: Dual regulation of
IL-1 beta-mediated matrix metalloproteinase-9 expression in
mesangial cells by NF-kappa B and AP-1. Am J Physiol.
270:F123–F130. 1996.PubMed/NCBI
|
|
46
|
Lungu G, Covaleda L, Mendes O,
Martini-Stoica H and Stoica G: FGF-1-induced matrix
metalloproteinase-9 expression in breast cancer cells is mediated
by increased activities of NF-kappaB and activating protein-1. Mol
Carcinog. 47:424–435. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yamamoto Y and Gaynor RB: Therapeutic
potential of inhibition of the NF-kappaB pathway in the treatment
of inflammation and cancer. J Clin Invest. 107:135–142. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yao J, Xiong S, Klos K, Nguyen N, Grijalva
R, Li P and Yu D: Multiple signaling pathways involved in
activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1
in human breast cancer cells. Oncogene. 20:8066–8074. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Amin AR Ruhul, Senga T, Oo ML, Thant AA
and Hamaguchi M: Secretion of matrix metalloproteinase-9 by the
proinflammatory cytokine, IL-1beta: A role for the dual signalling
pathways, Akt and Erk. Genes Cells. 8:515–523. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Marion-Letellier R, Déchelotte P, Iacucci
M and Ghosh S: Dietary modulation of peroxisome
proliferator-activated receptor gamma. Gut. 58:586–593. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Delerive P, Martin-Nizard F, Chinetti G,
Trottein F, Fruchart JC, Najib J, Duriez P and Staels B: Peroxisome
proliferator-activated receptor activators inhibit thrombin-induced
endothelin-1 production in human vascular endothelial cells by
inhibiting the activator protein-1 signaling pathway. Circ Res.
85:394–402. 1999. View Article : Google Scholar : PubMed/NCBI
|
